{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:51:08Z","timestamp":1791103868554,"version":"4.1.0"},"reference-count":170,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.mcna.2004.11.006","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:11Z","timestamp":1113835991000},"page":"419-445","source":"Crossref","is-referenced-by-count":55,"title":["Epidemiology and Risk Factors for Chronic Kidney Disease"],"prefix":"10.1016","volume":"89","author":[{"given":"William M.","family":"McClellan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2004.11.006_bib1","series-title":"Annual data report: atlas of end-stage renal disease in the United States","author":"US Renal Data System","year":"2002"},{"key":"10.1016\/j.mcna.2004.11.006_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3810\/pgm.2000.07.1166","article-title":"End-stage renal disease: are we ready for an emerging epidemic?","volume":"108","author":"Collins","year":"2000","journal-title":"Postgrad Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3810\/pgm.2001.09.1024","article-title":"The national epidemic of chronic kidney disease: what we know and what we can do","volume":"110","author":"Eknoyan","year":"2001","journal-title":"Postgrad Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/snep.2003.50009","article-title":"End-stage renal disease in the Asian-Pacific region","volume":"23","author":"Lee","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib5","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/ndt\/gfg233","article-title":"Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990\u20131999","volume":"18","author":"Stengel","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mcna.2004.11.006_bib6","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1046\/j.1523-1755.63.s83.24.x","article-title":"End-stage renal disease in India and Pakistan: burden of disease and management issues","volume":"83","author":"Sakhuja","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.mcna.2004.11.006_bib7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1525-1594.2002.07061.x","article-title":"Overview: end-stage renal disease in the developing world","volume":"26","author":"Barsoum","year":"2002","journal-title":"Artif Organs"},{"key":"10.1016\/j.mcna.2004.11.006_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1523-1755.2002.00426.x","article-title":"End-stage renal disease in developing countries","volume":"62","author":"Kher","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1681\/ASN.V2101502","article-title":"Rate of change of end-stage renal disease treatment incidence 1978\u20131987\u2014has there been selection?","volume":"2","author":"Rosansky","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0272-6386(12)80317-9","article-title":"Patterns of low incidence of treated end-stage renal disease among the elderly","volume":"20","author":"Moulton","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib11","first-page":"35","article-title":"Increasing incidence of end-stage renal disease in Wisconsin: an unintended consequence of increased survival?","volume":"100","author":"Russell","year":"2001","journal-title":"WMJ"},{"key":"10.1016\/j.mcna.2004.11.006_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/pmed.1998.0399","article-title":"Comparison of risk estimates for selected diseases and causes of death","volume":"28","author":"Merrill","year":"1999","journal-title":"Prev Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib13","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/01.ASN.0000014251.87778.01","article-title":"Cumulative risk for developing end-stage renal disease in the US population","volume":"13","author":"Kiberd","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib14","unstructured":"Statistics CMS. Medicare. Available at: http:\/\/www.cms.hhs.gov\/Review\/Supp\/. Accessed June 2004."},{"key":"10.1016\/j.mcna.2004.11.006_bib15","first-page":"s1","article-title":"K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0272-6386(03)00371-8","article-title":"Meeting the challenges of the new K\/DOQI guidelines","volume":"41","author":"Eknoyan","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/snep.2002.35973","article-title":"New clinical practice guidelines for chronic kidney disease: a framework for K\/DOQI","volume":"22","author":"Patel","year":"2002","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib18","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/ndt\/12.10.2060","article-title":"National Kidney Foundation: Dialysis Outcome Quality Initiative. Development of methodology for clinical practice guidelines","volume":"12","author":"Levin","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mcna.2004.11.006_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1073-4449(99)70005-1","article-title":"Forum of the End-Stage Renal Disease Networks' role in implementing the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines","volume":"6","author":"Diamond","year":"1999","journal-title":"Adv Ren Replace Ther"},{"key":"10.1016\/j.mcna.2004.11.006_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1053\/ajkd.2002.31999","article-title":"United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines","volume":"39","author":"Collins","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib21","series-title":"Healthy people: the Surgeon General's report on health promotion and disease prevention","author":"Department of Health Education, and Welfare","year":"1979"},{"key":"10.1016\/j.mcna.2004.11.006_bib22","series-title":"Healthy people 2000 final review","author":"National Center for Health Statistics","year":"2001"},{"key":"10.1016\/j.mcna.2004.11.006_bib23","first-page":"F85","article-title":"Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation","volume":"241","author":"Hostetter","year":"1981","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJM198209093071104","article-title":"Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease","volume":"307","author":"Brenner","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib25","first-page":"S124","article-title":"Nephron mass as a risk factor for progression of renal disease","volume":"63","author":"Brenner","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.mcna.2004.11.006_bib26","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0272-6386(03)00188-4","article-title":"Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes","volume":"41","author":"St Peter","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/ajkd.2000.8241","article-title":"Timing of nephrology referral: influence on mortality and morbidity","volume":"36","author":"Roubicek","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib28","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1681\/ASN.V1061281","article-title":"Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center","volume":"10","author":"Arora","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 6","key":"10.1016\/j.mcna.2004.11.006_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/14.suppl_6.16","article-title":"The pattern of referral of patients with end-stage renal disease to the nephrologist: a European survey","volume":"14","author":"Lameire","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mcna.2004.11.006_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/ajkd.1998.v32.pm9708613","article-title":"Early referral and its impact on emergent first dialyses, health care costs, and outcome","volume":"32","author":"Schmidt","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib31","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(01)06180-3","article-title":"Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. When to initiate dialysis: effect of proposed US guidelines on survival","volume":"358","author":"Korevaar","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.11.006_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/ajkd.2002.29896","volume":"39","author":"Korevaar","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/qjmed\/91.11.727","article-title":"Late referral of end-stage renal failure","volume":"91","author":"Ellis","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.mcna.2004.11.006_bib34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0272-6386(99)70226-X","article-title":"Delayed referral of black, Hispanic, and older patients with chronic renal failure","volume":"33","author":"Ifudu","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/ajkd.2001.25179","article-title":"Nonreferral and nonacceptance to dialysis by primary care physicians and nephrologists in Canada and the United States","volume":"38","author":"Sekkarie","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib36","first-page":"228","article-title":"Temporary vascular access for first dialysis is common, undesirable and usually avoidable","volume":"51","author":"Chesser","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib37","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0272-6386(98)70074-5","article-title":"Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey","volume":"32","author":"Jones","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib38","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/01.ASN.0000013291.78621.26","article-title":"Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III)","volume":"13","author":"Clase","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib40","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","article-title":"Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III","volume":"61","author":"Garg","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States","volume":"13","author":"Muntner","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib42","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.11.006_bib43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.25.4.587","article-title":"Early predictors of 15-year end-stage renal disease in hypertensive patients","volume":"25","author":"Perry","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.11.006_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199601043340103","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib45","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/01.HYP.0000069699.92349.8C","article-title":"Blood pressure predicts risk of developing end-stage renal disease in men and women","volume":"41","author":"Tozawa","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.11.006_bib46","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1097\/01.ASN.0000095249.99803.85","article-title":"Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington county, Maryland","volume":"14","author":"Haroun","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","article-title":"Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group","volume":"36","author":"Bakris","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/01.HYP.23.2.145","article-title":"National High Blood Pressure Education Program Working Group report on hypertension in diabetes","volume":"23","author":"National High Blood Pressure Education Program Working Group","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.11.006_bib49","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1001\/archinte.156.17.1938","article-title":"1995 update of the working group reports on chronic renal failure and renovascular hypertension","volume":"156","author":"National High Blood Pressure Education Program Working Group","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib50","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.11.006_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.299.6698.533","article-title":"Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy","volume":"299","author":"Parving","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2004.11.006_bib52","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.271.4.275","article-title":"Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group","volume":"271","author":"Viberti","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.11.006_bib54","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/ki.1996.480","article-title":"Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy","volume":"50","author":"Bakris","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib55","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib56","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1161\/01.HYP.29.3.744","article-title":"Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans","volume":"29","author":"Bakris","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.11.006_bib57","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/ki.1994.469","article-title":"Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group","volume":"46","author":"Hebert","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib58","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","volume":"349","author":"The GISEN Group","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.11.006_bib59","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/ki.1995.235","article-title":"Interaction of hypertension and diabetes on renal function in black NIDDM subjects","volume":"47","author":"Chaiken","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib60","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib61","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib62","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.11.006_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"AIPRD Study Group. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-118-2-199301150-00009","article-title":"Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis","volume":"118","author":"Kasiske","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib65","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0272-6386(00)70018-7","article-title":"Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials","volume":"35","author":"Kshirsagar","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib66","first-page":"837","article-title":"Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes","volume":"352","author":"Prospective Diabetes Study UK","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2004.11.006_bib67","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib68","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/ki.1995.236","article-title":"Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial","volume":"47","author":"The Diabetes Control and Complications (DCCT) Research Group","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.mcna.2004.11.006_bib70","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.18.8.1113","article-title":"Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes","volume":"18","author":"Abraira","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2004.11.006_bib71","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2169\/internalmedicine1962.30.618","article-title":"Determination of the glycemic threshold for the regression or prevention of diabetic microangiopathies, and the insulin injection regimen to establish strict glycemic control in NIDDM","volume":"30","author":"Kawamori","year":"1991","journal-title":"Jpn J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib72","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diacare.27.2007.S79","article-title":"Nephropathy in diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2004.11.006_bib73","first-page":"497","article-title":"Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. POSCH Group","volume":"36","author":"Matts","year":"1993","journal-title":"J Fam Pract"},{"key":"10.1016\/j.mcna.2004.11.006_bib74","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1046\/j.1523-1755.1999.0550031057.x","article-title":"Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5","volume":"55","author":"Anderson","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib75","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/01.CIR.102.24.2966","article-title":"Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?","volume":"102","author":"Rubenstein","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.11.006_bib76","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1523-1755.2001.00799.x","article-title":"Differential survival after coronary revascularization procedures among patients with renal insufficiency","volume":"60","author":"Szczech","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib77","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/01.CIR.0000016051.33225.33","article-title":"Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation","volume":"105","author":"Szczech","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.11.006_bib78","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0735-1097(00)00774-9","article-title":"Risks associated with renal dysfunction in patients in the coronary care unit","volume":"36","author":"McCullough","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib81","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib82","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/01.CIR.0000021597.63026.65","article-title":"Mild renal insufficiency is associated with angiographic coronary artery disease in women","volume":"105","author":"Reis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.11.006_bib83","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib84","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1046\/j.1523-1755.2002.00522.x","article-title":"Cardiovascular disease risk status in elderly persons with renal insufficiency","volume":"62","author":"Shlipak","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib85","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1067\/mhj.2002.125504","article-title":"Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction","volume":"144","author":"Walsh","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.mcna.2004.11.006_bib86","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","article-title":"Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes","volume":"106","author":"Al Suwaidi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.11.006_bib87","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/01.CIR.0000016359.94919.16","volume":"105","author":"Januzzi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.11.006_bib88","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0002-9149(03)00147-4","article-title":"Renal function and risk stratification in acute coronary syndromes","volume":"91","author":"Wison","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib89","doi-asserted-by":"crossref","first-page":"98","DOI":"10.7326\/0003-4819-138-2-200301210-00010","article-title":"Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency","volume":"138","author":"Tonelli","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib90","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0735-1097(02)02956-X","article-title":"Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb\/IIIa inhibitors","volume":"41","author":"Freeman","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib91","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1067\/mhj.2003.121","article-title":"Impact of renal function on morbidity and mortality after percutaneous aortocoronary saphenous vein graft intervention","volume":"145","author":"Gruberg","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.mcna.2004.11.006_bib92","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1523-1755.2003.00784.x","article-title":"Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions","volume":"63","author":"Reinecke","year":"2003","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.mcna.2004.11.006_bib93","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","article-title":"Renal function neurohormonal activation, and survival in patients with chronic heart failure","volume":"102","author":"Hillege","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.11.006_bib94","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0735-1097(02)02490-7","article-title":"Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure","volume":"40","author":"Kearney","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib95","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0735-1097(02)02125-3","article-title":"The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure","volume":"40","author":"Mahon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib96","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.CIR.102.2.203","article-title":"Renal function, neurohormonal activation, and survival in patients with chronic heart failure","volume":"102","author":"Hillege","year":"2000","journal-title":"Circulation"},{"issue":"4 Pt 1","key":"10.1016\/j.mcna.2004.11.006_bib97","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.25.4.587","article-title":"Early predictors of 15-year end-stage renal disease in hypertensive patients","volume":"25","author":"Perry","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.11.006_bib98","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/ajkd.1998.v31.pm9428448","article-title":"Clinical correlates of hypertensive end-stage renal disease","volume":"31","author":"Bleyer","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"17","key":"10.1016\/j.mcna.2004.11.006_bib99","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1097\/01.ASN.0000129982.10611.4C","article-title":"Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease","volume":"15","author":"McClellan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib100","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.1987.122","article-title":"Relationship between vascular disease and age-associated changes in the human kidney","volume":"31","author":"Kasiske","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib101","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2362.2003.01091.x","article-title":"SMART Study Group. Influence of atherosclerosis on age-related changes in renal size and function","volume":"33","author":"Bax","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.mcna.2004.11.006_bib102","first-page":"1253","article-title":"Low incidence of glomerulosclerosis in normal kidneys","volume":"113","author":"Smith","year":"1989","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib103","first-page":"251","article-title":"The relationship between atherosclerosis of the thoracic aorta and renal scarring in an autopsy material","volume":"93","author":"Jorgensen","year":"1985","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.mcna.2004.11.006_bib104","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0895-4356(88)90023-6","article-title":"A familial risk of chronic renal failure among blacks on dialysis?","volume":"41","author":"Ferguson","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib105","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1681\/ASN.V8121942","article-title":"Family history of end-stage renal disease among incident dialysis patients","volume":"8","author":"Freedman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib106","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1681\/ASN.V971270","article-title":"Familial aggregation of renal disease in a population-based case-control study","volume":"9","author":"Lei","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib107","first-page":"71","article-title":"Familial clustering of end-stage renal disease in Mississippi","volume":"43","author":"Butkus","year":"2002","journal-title":"J Miss State Med Assoc"},{"key":"10.1016\/j.mcna.2004.11.006_bib108","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1681\/ASN.V5101806","article-title":"Familial risk, age at onset, and cause of end-stage renal disease in white Americans","volume":"5","author":"Spray","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib109","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0272-6386(98)70135-0","article-title":"Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study","volume":"32","author":"O'Dea","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5694\/j.1326-5377.1993.tb137740.x","article-title":"Renal disease patterns in aboriginal Australians: a family-based study in a high incidence community","volume":"159","author":"Van Buynder","year":"1993","journal-title":"Med J Aust"},{"key":"10.1016\/j.mcna.2004.11.006_bib111","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1159\/000065029","article-title":"Familial aggregation of end-stage kidney disease in Brazil","volume":"91","author":"Queiroz Madeira","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.mcna.2004.11.006_bib112","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0272-6386(96)90356-X","article-title":"Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease","volume":"27","author":"Bergman","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib113","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1053\/ajkd.2002.36866","article-title":"Family members of patients treated for ESRD have high rates of undetected kidney disease","volume":"40","author":"Jurkovitz","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib114","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/01.ASN.0000018406.20282.C8","article-title":"Risk factors for proteinuria in a large, multiracial, southeast Asian population","volume":"13","author":"Ramirez","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1464-5491.2001.00406.x","article-title":"Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus","volume":"18","author":"Thompson","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib116","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM198905043201801","article-title":"Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy","volume":"320","author":"Seaquist","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib117","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00400098","article-title":"Diabetic nephropathy: a risk factor for diabetes mellitus in offspring","volume":"38","author":"McCance","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.mcna.2004.11.006_bib118","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s001250050754","article-title":"Clustering of albumin excretion rate abnormalities in caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group","volume":"40","author":"Faronato","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.mcna.2004.11.006_bib119","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0272-6386(95)90546-4","article-title":"Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus","volume":"25","author":"Freedman","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib120","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/diabetes.48.4.909","article-title":"Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients","volume":"48","author":"Canani","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2004.11.006_bib121","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0168-8227(99)00007-8","article-title":"Familial aggregation of diabetic kidney disease in type 2 diabetes in south India","volume":"43","author":"Vijay","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.mcna.2004.11.006_bib122","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00125-003-1095-7","article-title":"Renal disease in relatives of Indo-Asian type 2 diabetic patients with end-stage diabetic nephropathy","volume":"46","author":"Chandie Shaw","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.mcna.2004.11.006_bib123","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199203053261005","article-title":"Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy","volume":"326","author":"Earle","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib124","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2337\/diacare.21.9.1545","article-title":"Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy","volume":"21","author":"Canani","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2004.11.006_bib125","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2337\/diacare.22.3.422","article-title":"Diabetic nephropathy is associated with an increased familial risk of stroke","volume":"22","author":"Lindsay","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2004.11.006_bib126","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib127","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","article-title":"Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease","volume":"2","author":"Moorhead","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.11.006_bib128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3949\/ccjm.57.7.599","article-title":"Lipoprotein abnormalities in the progression of renal disease","volume":"57","author":"Brouhard","year":"1990","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib129","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","article-title":"Effect of lipid reduction on the progression of renal disease: a meta-analysis","volume":"59","author":"Fried","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib130","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1046\/j.1523-1755.1998.00067.x","article-title":"Smoking as a risk factor for end-stage renal failure in men with primary renal disease","volume":"54","author":"Orth","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000441-200402000-00001","article-title":"Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes","volume":"327","author":"Chuahirun","year":"2004","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.mcna.2004.11.006_bib132","first-page":"270","article-title":"Stopping smoking slows accelerated progression of renal failure in primary renal disease","volume":"15","author":"Schiffl","year":"2002","journal-title":"J Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib133","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1523-1755.2000.00284.x","article-title":"Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population","volume":"58","author":"Halimi","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib134","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bmj.304.6821.216","article-title":"Controlled low protein diets in chronic renal insufficiency: meta-analysis","volume":"304","author":"Fouque","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2004.11.006_bib135","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/ndt\/15.12.1986","article-title":"Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure","volume":"15","author":"Fouque","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mcna.2004.11.006_bib136","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1053\/ajkd.1998.v31.pm9631839","article-title":"A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function","volume":"31","author":"Kasiske","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib137","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-124-7-199604010-00002","article-title":"The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis","volume":"124","author":"Pedrini","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib138","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/ajkd.2003.50119","article-title":"Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey","volume":"41","author":"Wrone","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib139","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7326\/0003-4819-138-6-200303180-00009","article-title":"The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency","volume":"138","author":"Knight","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib140","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.EDE.0000071413.55296.c4","article-title":"Lifestyle factors, obesity and the risk of chronic kidney disease","volume":"14","author":"Stengel","year":"2003","journal-title":"Epidemiology"},{"key":"10.1016\/j.mcna.2004.11.006_bib141","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1047-2797(03)00066-8","article-title":"Lifestyle risk factors and chronic kidney disease","volume":"13","author":"Vupputuri","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.mcna.2004.11.006_bib142","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.11.006_bib143","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00467-002-0863-9","article-title":"Body mass index and allograft function in pediatric renal transplantation","volume":"17","author":"Mitsnefes","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib144","first-page":"203","article-title":"Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy","volume":"13","author":"Solerte","year":"1989","journal-title":"Int J Obes"},{"key":"10.1016\/j.mcna.2004.11.006_bib145","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/01.ASN.0000068462.38661.89","article-title":"The effects of weight loss on renal function in patients with severe obesity","volume":"14","author":"Chagnac","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib146","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s001250050694","article-title":"Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients","volume":"40","author":"Yokoyama","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.mcna.2004.11.006_bib147","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-134-5-200103060-00009","article-title":"Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data","volume":"134","author":"ACE Inhibitors in Diabetic Nephropathy Trialist Group","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib148","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib149","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1523-1755.1998.00874.x","article-title":"Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN)","volume":"53","author":"Ruggenenti","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib150","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.11.006_bib151","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","article-title":"Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States","volume":"14","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib152","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2105\/AJPH.88.9.1297","article-title":"Comment: abandoning \u201crace\u201d as a variable in public health research\u2014an idea whose time has come","volume":"88","author":"Fullilove","year":"1998","journal-title":"Am J Public Health"},{"key":"10.1016\/j.mcna.2004.11.006_bib153","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.publhealth.24.100901.140927","article-title":"Classification of race and ethnicity: implications for public health","volume":"24","author":"Mays","year":"2003","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.mcna.2004.11.006_bib154","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1353\/pbm.2002.0023","article-title":"Race, ethnicity, and health: can genetics explain disparities?","volume":"45","author":"Braun","year":"2002","journal-title":"Perspect Biol Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib155","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/01.ASN.0000026493.18542.6A","article-title":"Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors","volume":"13","author":"Tarver-Carr","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib156","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJM198903163201102","article-title":"Renal insufficiency in treated essential hypertension","volume":"320","author":"Rostand","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib157","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1097\/01.ASN.0000083392.11042.14","article-title":"Racial differences in early-onset renal disease among young adults: the coronary artery risk development in young adults (CARDIA) study","volume":"14","author":"Stehman-Breen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib158","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/archinte.151.7.1359","article-title":"Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?","volume":"151","author":"Whittle","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib159","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1001\/jama.268.21.3079","article-title":"The excess incidence of diabetic end-stage renal disease among blacks: a population-based study of potential explanatory factors","volume":"268","author":"Brancati","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.11.006_bib160","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archinte.155.11.1201","article-title":"Race and end-stage renal disease: socioeconomic status and access to health care as mediating factors","volume":"155","author":"Perneger","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mcna.2004.11.006_bib161","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.278.23.2069","article-title":"Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial","volume":"278","author":"Brancati","year":"1997","journal-title":"JAMA"},{"issue":"5 Suppl","key":"10.1016\/j.mcna.2004.11.006_bib162","doi-asserted-by":"crossref","first-page":"I80","DOI":"10.1161\/01.HYP.13.5_Suppl.I80","article-title":"Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group","volume":"13","author":"Shulman","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.11.006_bib163","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1001\/jama.268.21.3085","article-title":"Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. The MRFIT Research Group","volume":"268","author":"Walker","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.11.006_bib164","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1046\/j.1523-1755.1998.06815.x","article-title":"Hypertension as cause of end-stage renal disease: lessons from international registries","volume":"68","author":"Valderrabano","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.mcna.2004.11.006_bib165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00041552-200205000-00012","article-title":"Regional variation in end-stage renal disease","volume":"11","author":"Usami","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.mcna.2004.11.006_bib166","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0272-6386(12)80317-9","article-title":"Patterns of low incidence of treated end-stage renal disease among the elderly","volume":"20","author":"Moulton","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib167","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1681\/ASN.V261144","article-title":"Geographic variation in the incidence of treated end-stage renal disease","volume":"2","author":"Foxman","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mcna.2004.11.006_bib168","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ki.1994.120","article-title":"Socioeconomic status and end-stage renal disease in the United States","volume":"45","author":"Young","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2004.11.006_bib169","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0272-6386(12)80806-7","article-title":"Race, socioeconomic status, and the development of end-stage renal disease","volume":"23","author":"Byrne","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mcna.2004.11.006_bib170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0272-6386(03)00649-8","article-title":"Receipt of renal replacement therapy in the United States: a population-based study of sociodemographic disparities from the Second National Health and Nutrition Examination Survey (NHANES II)","volume":"42","author":"Powe","year":"2003","journal-title":"Am J Kidney Dis"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712504001828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712504001828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:28:01Z","timestamp":1625786881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712504001828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":170,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0025712504001828"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2004.11.006","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}